Research Projects of SFB1399

Our consortium is highly interdisciplinary, covering expertise in biochemistry and signaling, structural biology, medicinal chemistry and structure-guided drug design, cancer immunology and inflammation, mouse models, cancer genomics, computational genomics, molecular pathology, as well as clinical trials.

SFB 1399 Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer

SFB 1399 Mechanisms of Drug Sensitivity
and Resistance in Small Cell Lung Cancer

c/o Department of Translational Genomics
University of Cologne
Weyertal 115b
50931 Cologne, Germany

+49-221-478-98777
info[@]sfb1399.de

Imprint
Privacy Policy

Partners:

University of Cologne University Hospital of Cologne University Hospital Essen Max Planck Institute for Metabolism Research TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Main University of Bonn University of Frankfurt Deutsche Forschungsgemeinschaft CIO Centrum für integrierte Onkologie Aachen Köln Bonn Düsseldorf Lung Cancer Group Cologne